Shares in Biohaven moved up about 7% on Friday after the company provided an update with respect to its New Drug Application (NDA) for troriluzole for the treatment of adult patients with ...

Dutch immunology company argenx has announced positive top-line data from the pivotal ADAPT SERON Phase III study of Vyvgart ...

Founded in 2016 and headquartered in San Francisco, Multiply Labs designs robotic manufacturing systems for personalized ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...